← Evidence map

ArticleTherapeutic advances in urology

Real-world use of enfortumab vedotin in metastatic urothelial carcinoma: efficacy, safety, and risk stratification.

Martina Catalano et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

3 papers cite it

2026
cites it
Full record →Abstract, authors, funding and every citing paper · PMID 41555863